Brought to you by 
Tularik, Amgen discover and develop cancer therapeutics
12 Jun 2003
Executive Summary
Tularik and Amgen will work together on the discovery, development and marketing of oncology therapeutics over a five-year period. Amgen will initially choose development projects from Tularik's targets but expects to expand beyond these 30 amplified oncogenes.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Includes Contract
- Includes Equity
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Tularik, Amgen discover and develop cancer therapeutics
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice